Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines

Cancer Letters

Volumn 151, Issue 2, 2000, Pages 199-208

  Hayashi, Ken ^a   Yokozaki, Hiroshi ^a   Naka, Kazuhito ^a   Yasui, Wataru ^a   Yajin, Koji ^a   Lotan, Reuben ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer therapy; Cytostatic effect; Growth arrest; Retinoic acid receptor

Indexed keywords

ALITRETINOIN; PROTEIN P53; RETINOIC ACID RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HUMANS; MOUTH NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034646895     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00422-X     Document Type: Article

References (45)

1. Gudas L.J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Diff. 3:1992;655-662.
2. Jetten A.M., Nervi C., Vollberg T.M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoid. JNCI Monogr. 13:1992;93-100.
3. Lotan R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res. 54:1994;1987-1990.
4. Love J.M., Gudas L.J. Vitamin A, differentiation and cancer. Curr. Opin. Cell Biol. 6:1994;825-831.
5. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., Byers R.M., Schantz S.S., Kramer A.M., Lotan R., Peters L.L., Dimery I.W., Brown B.W., Goepfert H. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med. 323:1990;795-801.
6. DeLuca L.M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5:1991;2924-2933.
7. Lotan R., Xu C., Lippman S.M., Ro J.Y., Lee J.S., Lee J.J., Hong W.K. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N. Eng. J. Med. 332:1995;1405-1410.
8. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
9. Oridate N., Esumi N., Lotan D., Hong W.K., Rochette-Egly C., Chambon P., Lotan R. Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene. 12:1996;2019-2028.
10. de Thè H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor-β gene. Nature (Lond.). 343:1990;177-180.
11. Seewaldt V.L., Joffnson B.S., Perker M.B., Collins S.J., Swisshelm K. Expression of retinoic acid receptor-β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6:1995;1077-1088.
12. Leroy P., Krust A., Kastner C., Mendelsohn A., Zelent P. Chambon, Retinoic acid receptors. Morriss-Kay G. Retinoids in Normal Development and Teratogenesis. 1992;7-25 Oxford University Press, New York.
13. Mangelsdsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 89:1995;841-850.
14. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
15. Yokozaki H., Tortora G., Pepe S., Maronde E., Genieser H.-G., Jastorff B., Cho-Chung Y.S. Unhydrolyzable analogues of adenosine 3′:5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 52:1992;2504-2508.
16. Yoshida K., Tsuda T., Matsumura T., Tsujino T., Hattori T., Ito H., Tahara E. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch. B. Cell Pathol. 57:1989;285-290.
17. Zou C.P., Clifford J.L., Xu X.C., Sacks P.G., Chambon P., Hong W.K., Lotan R. Modulation by retinoic acid (RA) binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res. 54:1994;5479-5487.
18. Kameda T., Yasui W., Yoshida K., Tsujino T., Nakayama H., Ito M., Ito H., Tahara E. Expression of ERBB2 in human gastric carcinomas: relationship between p185 expression and the gene amplification. Cancer Res. 50:1990;8002-8009.
19. Rubin M., Fenig E., Rosenauer A., Menendez-Botet C., Achkar C., Bentel J.M., Yahalom J., Mendelsohn J., Miller W.H. Jr. 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res. 54:1994;6549-6556.
20. Naka K., Yokozaki H., Domen T., Hayashi K., Kuniyasu H., Yasui W., Lotan R., Tahara E. Growth inhibition of cultured human gasric cancer cells by 9-cis-RA with inhibition of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. Differentiation. 61:1997;313-320.
21. Sakai E., Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 7:1992;927-933.
22. Akagi M., Yasui W., Akama Y., Yokozaki H., Tahara H., Haruma K., Kajiyama G., Tahara E. Inhibition of cell growth by transforming growth factor-β is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn. J. Cancer Res. 87:1996;377-384.
23. Liu M., Iavarone A., Freedman L.P. Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J. Biol. Chem. 271:1996;31723-31728.
24. Jiang H., Lin J., Su Z.-Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
25. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., El-Houseini M.E. Induction of p21WAF1/CIP1 during differentiation. Oncogene. 9:1994;3389-3396.
26. Shao Z.-M., Dawson M.I., Li X.S., Rishi A.K., Sheikh M.S., Han Q.-X., Ordones J.V., Shroot B., Fontana J.A. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene. 11:1995;493-504.
27. Kuniyasu H., Yasui W., Kitahara K., Naka K., Yokozaki H., Akama Y., Hamamoto T., Tahara H., Tahara E. Growth inhibitory effect of Interferon-β is associated with the induction of cyclin-dependent kinase inhibitor p27kip1 in a human gastric garcinoma cell line. Cell Growth Diff. 8:1997;47-52.
28. Polyak K., Kato J.Y., Solomon M.J., Sheer C.J., Massaguè J., Roberts J.M., Koff A. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
29. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
30. Kawasaki H., Eckner R., Yao T.-P., Taira K., Chiu R., Livingston D.M., Yokoyama K.K. Distinct roles of the co-activators p300 and CBP in retinoic acid induced F9 cell differentiation. Nature (Lond.). 393:1998;284-289.
31. Dulic V., Kaufman W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., Elledge S.J., Reeds S.I. p53 dependent inhibition of cyclin dependent kinase activities in human fibroblasts during radiation induced G1 arrest. Cell. 76:1994;1013-1023.
32. Haper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell. 75:1993;805-816.
33. Winston J., Dong F., Pledger W.J. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271:1996;11253-11260.
34. Mehta K., Mcqueen T., Meamati N., Collins S., Andreef M. Activation of retinoid receptors RARα and RXRα induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Diff. 7:1996;179-186.
35. Nagy L., Thomázy V.A., Shipley G.L., Fésüs L., Lamph W., Heyman R.A., Chandraratana R.A.S., Davies P.J.A. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:1995;3540-3551.
36. Fisher R.P., Morgan D.O. novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell. 78:1994;713-724.
37. Mäkelä T.P., Tassan J.P., Nigg E.A., Frutiger S., Hughes G.J., Weinberg R.A. A cyclin associated with the CDK-activating kinase MO15. Nature (Lond.). 371:1994;254-257.
38. Yen A., Varvayanis S. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Exp. Cell Res. 214:1994;250-257.
39. Yen A., Varvayanis S. phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3. J. Cell Physiol. 163:1995;502-509.
40. Okazawa H., Shimizu J., Kamei M., Imafuku I., Hamada H., Kanazawa I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J. Cell. Biol. 132:1996;955-968.
41. Sato T., Handa M., Bodrug S., Irie S., Iwama N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.-G., Reed J.C. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA. 91:1994;9238-9242.
42. Xu X.C., Liu X., Tahara E., Lippman S.M., Lotan R. Expression and up-regulation of retinoic acid receptor-β is associated with retinoic sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 59:1999;2477-2483.
43. Nicke B., Riecken E.O., Rosewicz S. Induction of retinoic acid receptor beta mediates growth inhibition in retinoid resistant human colon carcinoma cells. Gut. 45:1999;51-57.
44. Faria T.N., Mendelsohn C., Chambon P., Gudas L.J. The targeted disruption of both alleles of RAR beta (2) in F9 cells results in the loss of retioic acid-associated growth arrest. J. Biol. Chem. 274:1999;26783-26788.
45. Liu G., Wu M., Levi G., Ferrari N. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. Int. J. Cancer. 78:1998;248-254.